Manuel Crespo

Pharmacokinetic Interaction Between Nevirapine and Rifampicin in HIV-Infected Patients With Tuberculosis

Esteban Ribera, Leonor Pou, Rosa María López et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 143 citations

Drug Interactions, Steady State, Pharmacology +13

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

José Ramón Arribas, Pierre‐Marie Girard, Roland Landman et al. · The Lancet Infectious Diseases · 2015 · 142 citations · Full text

Hiv/aids Counselling, Human Retrovirus, Antiviral Drug Development +9

Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study

Alexandre Pérez‐González, Alejandro Araújo-Ameijeiras, Alberto Fernández‐Villar et al. · Scientific Reports · 2022 · 119 citations · Full text

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

Cesar Fisac, Emilio Fumero, Manuel Crespo et al. · AIDS · 2005 · 115 citations

Body composition changes after switching from protease inhibitors to raltegravir

Adrián Curran, Estebán Martínez, María Saumoy et al. · AIDS · 2011 · 66 citations